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p < 0.0001). loss of this improvement during follow-up was relatively high
(loss index = 0.86 vs 0.44, P = 0.013), so that the net improvement at 6
months was one third that seen with the more severe stenoses (net gain =
0.17 vs 0.48 mm, p < 0.0001). Moreover, a substantial proportion of stenoses
were more severely narrowed 6 months after the procedure than before
(29.0% YS 15.4%, P < 0.0001).
Conclusion. Treatment of "insignificant" stenoses is relativelyfrequent. De-
spite more aggressive balloon sizing, short and intermediate term results are
disappointing.
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1761-41 Angloplasty in Borderline Lesions of <50% Diameter
Stenosis for Unstable or Post-Infarction Angina is not
a Benign Procedure
Waqar H. Ahmed, Clyde R. Meckel. Robert N. Piana. Deborah Manuelian,
Burt Adelman. John A. Bittl, Hirulog Angioplasty Study Investigators. Brigham and
Women:' Hospital, Boston, MA
Absence of a significant lesion of :;:50% diameter stenosis is considered
a contraindication to PTCA. In unstable or post-infarction angina, however,
PTCA of borderline lesions of <50% diameter stenosis may be warranted
because of the dynamic nature of cyclic flow reduction due to intermittent
platelet plugging. To define the clinical and angiographic outcome of PTCA of
borderline lesions, we analyzed the results in patients undergoing PTCA for
unstable or post-infarction angina in the Hirulog ,. Angioplasty Study. Of 3051
patients with validated clinical data and films analyzed in the Core Angio-
graphic Laboratory, 227 (7.4%) had PTCA performed exclusively for lesions
<50% diameter stenosis. In this group of patients, the mean pre-treatment
stenosis was 40 ± 9% (range, 0-49.9%). and the mean post-angioplasty
stenosis was 26 ± 15% (range, -20-100%). In comparison with patients
with more severe lesions, patients with borderline lesions of <50% stenosis
had similar age, sex distribution, incidence of rest angina, and PTCA compli-
cation rates:
<50% stenosis ?:50% stenosis Pvalue
n 227 2824
Procedural success (%) 93.0 851 0001
Abrupt vessel closure (%) 49 5.8 0.55
Death (%) 00 0.5 0.31
Myocardial infarction (%) 2.6 3.2 067
Emergency bypass (%) 2.2 2.2 0.99
Clinical restenosis (%) 113 13.1 0.60
Clinical restenosis results at 6 months (death. MI, or revascularization)
were available for 1387 (45%) patients.
In summary, these results suggest that PTCA of lesions <50% diameter
stenosis is not a benign procedure and carries similar risks as PTCA for more
severe lesions. This warrants a cautious approach to intervention in such
lesions and further study into their natural history.
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1761-51 Evolution of Angiographic Thrombus Formation and
Dissection Following PTCA in Unstable Angina
John A. Ambrose. Orlandino D. Almeida. Denise Ratner, Samin K. Sharma,
Jonathan D. Marmur, Sabino Torre, Douglas Israel. TAUSA trial. Mount Sinai
Hospital. New York, NY
Acute closure and adverse in hospital clinical events are increased following
PTCA in unstable angina. Both thrombus (T) and dissection (D) post PTCA
are associated with increased adverse events. However, the time course of
development of T or D post PTCA has not been studied. In the TAUSA trial,
unstable angina patients were blindly randomized to intracoronary Urokinase
or placebo administered during and immediately following PTCA of the cul-
prit lesion. Angiograms were read blindly by a core lab and characterized at
1 & 15 minutes following PTCA for T or D. D was divided into minor (linear
extraluminal cap without luminal compromise) and major (spiral D or D caus-
ing >50% diameter reduction). T was defined as one or more filling defects
at the PTCA site.
Thrombus Major Dissection
1 min. 15 min. 1 min. 15 min.
All pts (n = 4591 4.4% 14.8%* 6.7% 9.2%
Urokinase (n = 2261 4.1% 11.9°/0* 5.9% 10.1%t
Placebo (n = 233) 4.8% 17.5%* 7.4% 8.3%
• p < 0.00515 min. vs. 1 min.; t p = 0.10 15 min. vs 1 min.; all other NS
For all pts and for Urokinase and Placebo, angiographic T increased at 15
vs. 1 min post PTCA. There was a trend to an increase in major D with Uroki-
nase at 15 min but not in the placebo group. Any D (major or minor) was
noted with placebo in 24% and 29% at 1 and 15 min. respectively and in
27% and 32% with Urokinase, p = NS. Thus, T formation develops gradu-
ally following PTCA and is time dependent probably related to activation of
coagulation. D is usually present immediately after PTCA secondary to the
mechanical trauma of balloon' dilatation. Urokinase given immediately after
PTCA may increase the evolution to major D.
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PTCA in the Elderly: Epidemiology, Clinical Risk
Factors and Their Relationship to Outcomes
David Wennberg, David J. Malenka, John Robb, Mirle A. Kellett Jr.,
Samuel Shubrooks, William A. Bradley, Michael J. Hearne, Peter VerLee,
Hebe Quinton, Gerald T. O·Connor. Northern New England Cardiovascular Disease
Study Group. Dartmouth-Hitchcock Medical Center, Lebanon NH
We report on 521 patients :;:80 years old (AGED) from a regional, population-
based study of 12,902 hospitalizations for PTCA between 10/89-12/93. Over
this time period, the proportion of AGED doubled to 4.4%. Compared to
younger patients, AGED were more likely female, had fewer cardiac risk fac-
tors and more severe coronary disease. They had more urgent procedures
and more complex lesion type. AGED clinical success was 91.36%. Their risk
of nonfatal M I or CABG was similar to younger patients.
Age ~59 60-69 70-79 ~80
(n = 5591) (n = 3968) (n = 2822) (n = 521)
Female (%1 22.4 33.2 45.5 56.5 t
Smokers (%1 47.6 27.2 16.0 10.4t
Multiwvessel disease (%) 319 39.8 45.1 57.9 t
Lesion type B/C (%) 50.7 53.0 53.4 59.6 t
Priority urgent (%) 575 58.6 61.9 72.2 t
Nonfatal MIlCABG (%) 459 5.09 4.53 519
Death (%) 0.27 0.76 1.91 3.45t
Clinical Success* (%) 95.14 94.15 93.58 91.36t
Multivariate OR Death (%) 1 2.46 6.33 9.09
(t P < 001)(* no MI/CABG/Death and ~1 lesions dilated)
Their risk of death was substantially increased and remained increased
in a multivariate model controlling for risk factors. We conclude that clini-
cal success following PTCA for the AGED is good. However, they have an
increased risk of fatal outcomes following PTCA. This information may be
helpful in counseling the rapidly growing number of AGED patients contem-
plating PTCA.
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A Study in Ventricular-Ventricular Interaction: Single
Right Ventricles Compared with Systemic Right
Ventricles In a Dual Chambered Circulation
Mark A. Fogel. Paul M. Weinberg, Kenneth E. Fellows. Eric A. Hoffman. The
Children's Hospital ofPhiladelphia, Philadelphia. PA 19104
Ventricular-ventricular interaction (W) is known to occur in the normal hu-
man heart. Because a subgroup of single right ventricle pts who have under-
gone the Fontan procedure (F) present in ventricular failure, we compared
systemic right ventricles with and withoul a mechanically coupled left ventri-
cle to determine the biomechanical effects of ventricular interdependence.
A magnetic resonance tagging technique which lays stripes down on the
myocardium called spatial modulation of magnetization was employed to
examine 18 pts with systemic right ventricles: 7 F and 11 with transposition
of the great arteries who have undergone an atrial inversion operation (Ala).
The systolic motion of the intersection points were tracked to determine re-
gional twist, radial motion and finite strain analysis was applied to the grid
lines to derive principle E1 strains at the atioventricular and apical short axis
levels and in 4 anatomic wall regions.
Strain: Strain was greatest (-0.2 ± 0.02 at the posterior wall at the atri-
oventricular valve) and heterogeneity of strain least (coefficient of variation
0.46 ± 0.03 at the inferior wall at the atrioventricular valve) in pts with Ala
(6/8 regions). Marked differences were noted in strain distribution within a
given region, from endocardium to epicardium (strain distribution across the
thickness of the myocardium). and from atrioventricular valve to apex (strain
distribution along the ventricular long axis) between pt subtypes and the nor-
malleft ventricle.
